Luigi Coltelli

Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for <i>RAS</i> and <i>BRAF</i> Wild-type Metastatic Colorectal Cancer

Chiara Cremolini, Carlotta Antoniotti, Sara Lonardi et al. · JAMA Oncology · 2018 · 114 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Cardioprotective Strategy for Patients With Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy

Lorenzo Livi, Giuseppe Barletta, Francesca Martella et al. · JAMA Oncology · 2021 · 71 citations · Full text

Medicine, Oncology, Pharmacology +16

Genetic interaction of<i>P2X7</i>receptor and<i>VEGFR-2</i>polymorphisms identifies a favorable prognostic profile in prostate cancer patients

Anna Solini, Vittorio Simeon, Lisa Derosa et al. · Oncotarget · 2015 · 30 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE

Silvana Leo, Ermenegildo Arnoldi, Lazzaro Repetto et al. · The Oncologist · 2018 · 21 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Pharmacogenetic Interaction Analysis of <i>VEGFR-2</i> and <i>IL-8</i> Polymorphisms in Advanced Breast Cancer Patients Treated with Paclitaxel and Bevacizumab

Giacomo Allegrini, Luigi Coltelli, Paola Orlandi et al. · Pharmacogenomics · 2014 · 15 citations

Medicine, Oncology, Pharmacology +17